These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9851186)
41. The role of markers of bone remodeling in multiple myeloma. Terpos E; Politou M; Rahemtulla A Blood Rev; 2005 May; 19(3):125-42. PubMed ID: 15748961 [TBL] [Abstract][Full Text] [Related]
42. Correspondence re: J. Lu et al., thalidomide metabolites in mice and patients with multiple myeloma. Clin. Cancer Res., 9: 1680-1688, 2003. Zhou S Clin Cancer Res; 2003 Nov; 9(14):5429; author reply 5429. PubMed ID: 14614031 [No Abstract] [Full Text] [Related]
43. Multiple myeloma in a patient with hoarseness, dysphagia, aspiration, and cervical lymphadenopathy. Fortson JK; Nuriddin A; McCarter F; Henderson VJ; Patel V Ear Nose Throat J; 2004 Apr; 83(4):274, 276-7. PubMed ID: 15147100 [TBL] [Abstract][Full Text] [Related]
44. [Influence of thalidomide on interleukin-6 and its transmission in multiple myeloma patients]. Li J; Luo S; Hong W; Zhou Z; Zou W Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):254-6. PubMed ID: 12515619 [TBL] [Abstract][Full Text] [Related]
45. Current status of new drugs for the treatment of patients with multiple myeloma. Kenealy M; Prince HM Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741 [TBL] [Abstract][Full Text] [Related]
46. Hyperammonemic encephalopathy in a patient with primary hepatic neuroendocrine carcinoma. Turken O; Basekim C; Haholu A; Karagoz B; Bilgi O; Ozgun A; Kucukardali Y; Narin Y; Yazgan Y; Kandemir EG Med Oncol; 2009; 26(3):309-13. PubMed ID: 19031017 [TBL] [Abstract][Full Text] [Related]
47. Hyperammonemia and encephalopathy in patients with multiple myeloma. Talamo G; Cavallo F; Zangari M; Barlogie B; Lee CK; Pineda-Roman M; Kiwan E; Krishna S; Tricot G Am J Hematol; 2007 May; 82(5):414-5. PubMed ID: 17133420 [No Abstract] [Full Text] [Related]
48. Hyperammonemia in multiple myeloma. Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062 [TBL] [Abstract][Full Text] [Related]
49. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia]. Kozuka T; Fukuda S; Imai T; Sezaki T Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443 [TBL] [Abstract][Full Text] [Related]
50. Serum amino acid disturbance in multiple myeloma with hyperammonemia. Matsuzaki H; Hata H; Sonoki T; Matsuno F; Kuribayashi N; Yoshida M; Nagasaki A; Murata H; Fujiyama S; Takatsuki K Int J Hematol; 1995 Apr; 61(3):131-7. PubMed ID: 7599324 [TBL] [Abstract][Full Text] [Related]